Azotemic renal osteodystrophy is a difficult complication to the end-stage chronic renal failure. It becomes increasingly important as the uremic state is sustained for a long term by hemodialysis (Kim, et al., Pendras, 1969 Endocrinol. Japon. June1979
Moreover, high values of iPTH were observed in the plasma from29of30pa-tients with normal alkaline phosphatase. After5hours hemodialysis using7.5mg/dl dialysate calcium plasma iPTH values somewhat decreased, but fully recovered until the next hemodialysis (Fig.3) .
These results indicate the difficulty in the effcetive suppression of the secondary hyperparathyroidism by7.5mg/dl dialysate calcium.
Bone histology Bone histologic changes can be calssified into the following4groups by histomorphometry with reference to normal control values (Mori et al., 1976) as shown in Fig.   Fig.3 4. The osteoid excess pgrou corresponds to osteomalacia tha is caused by vitamin D defficiency, and the resorption excess group reflects ostestis fibrosa due to secondary hyperparathyroidism. Bidirectional excess osteoid and resorption group is considered to be the mixed type of both osteomalacia and osteitis fibrosa. Normal values of osteoid and resorption indicate the normal group. Thickness of osteoid seam is measured from an another aspect of osteomalacia.
(
1) Patients under dietary control period
No patients out of12fitted to the normal range group. Seven belonged to the osteoid excess group. One showed resorption excess and4setteled in bidirectional excess (Fig.5) .
Therefore, in patients under dietary control, osteomalacic changes were frequently observed rather than osteitis fiblosa.
(2) Patients on long term hemodialysis period 42patients were examined in3series acooding to the length of hemodialysis treatment as follows: 19 (14males, 5females). treated for between1-11months, 10 (5 males, 5females) treated for between12-35months, and13 (7males, 6females) treated for between36-85months. Osteo malacia, osteotis fibrosa and the mixed type of both chages are distributed rather evenly in the patients treated for1-11 months (Fig.6) . Based on these results, it seems most likely that the hemodialysis treatment caused secondary hyperparathyrodism. In addision, the mixed type of both osteomalacia and osteitis fibrosa was common but simple osteomalacia or osteitis fibrosa selum appeared when the treatment exceeded36months (Fig.7) . Endocrinol. Japon. June1979 
Discussion
For the prevention of azotemic renal osteodystrophy, the administration of almigel for hyperphosphatemia (Pendras, 1966) or large amount of calcium for hypocalcemia (Davidson and Pendras, 1967) had been attempted.
The adjustment of dialysate calcium concentrations against hypocalcemia have been discussed (Goldsmith et al., 1971) . However, the azotemic renal osteodystrophy is not a negligible complication in long term hemodialysis (Ritz et al., 1971) . We also paied great attention to prevent the complication, but the results were not satisfactory as shown in this report.
Elevation of alkaline phosphatase in course of long term hemodialysis is essentially dependent upon the calcium consentration of the dialysate (Massry et al., 1969) . The dialysate calcium of6.0mg/dl were not sufficient in our result. By contrast, 5.0mg/dl dialysate calcium induced no vascular calcifications but many fracture in the other center. The7.5mg/dl dialysate calcium are insufficient to suppress plasma iPTH in our results, but8.0mg/dl may be useful (Goldsmith et al., 1971) . The higher calcium concentration of dialysate would be harmful, particularly if the serum phos- Endocrinol. Japon. June1979 phote levels are not well controlled.
It was pointed out many years ago that chronic renal failure might to be accompanied by osteomalacia (Barber, 1926) or osteitis fibrosa (Albright et al., 1935) . or both (Follis and Jackson, 1943) . Osteomalacia is due to lack of vitamin D and osteitisfibrosa is derived from hyperparathyroidism (Stanbury et al., 1969) .
We observed that osteomalacic changes rather than osteitis fibrosa were predominant in patients with chronic renal failure with GPR of5-30ml/min. Bouncci at al. (1975) pointed out that osteomalacia is the main pathological feature in60% of40 patients with3-40ml/min GFR. By Malluche et al.(1975) , the primary changes of hyperparathyroidism exhited mineralisation defect below 40ml/min GFR. Another report (Bordier, 1975) suggested that osteomalacia was superimposed on the early stage of osteitis fibrosa in the progressive course of chronic renal failure.
A number of investigators have reported the bone changes in patients on long term hemodialysis (Kaye, 1971; Sherard et al., 1972) .
The major disorders are osteomalacia, osteitis fibrosa and osteoporosis. Abnormal collagen metabolism in bone was also mentioned (Avioli, 1973) . Serial bone biopsies revealed the progression of osteomalacia and osteitis fibrosa in maintenance hemodialysis (Bonomini, 1975) . We also recognized the advancing pattern of bone disease in the course of hemodialysis.
Dialysate calcium concentrations were responsible for bone disease (de Veber, 1970; Jowsey et al., 1972) . High-calcium dialysate may improve bon disease throgh suppressing secondary hyperparathyroidism (Goldsmith et al., 1971) .
Both DHT and la-OH-D3are analogues of active vitamin D. When hydroxylated in the liver at the25position, those have similar steric configurations to la, 254011)2-D3. Synthetic la, 25-(OH)2-D3corrects the calcium balance and increases the serum calcium (Brickman et al., 1972) (Naik et al., 1976) .
